A Multicentre Randomized, Double-blind, Placebo Controlled, Dose-finding, Phase 2 Study (MARS-17) of GSK3858279 in Adult Participants With Moderate to Severe Pain Due to Knee Osteoarthritis
A Multicentre Randomized, Double-blind, Placebo Controlled, Dose-finding, Phase 2 Study (MARS-17) of GSK3858279 in Adult Participants With Moderate to Severe Pain Due to Knee Osteoarthritis
This is dose-finding study of GSK3858279 in participants with moderate to severe knee osteoarthritis pain. The purpose of this study is to investigate and provide the data necessary to select the optimal effective and safe dose(s) of GSK3858279.
Inclusion Criteria:
Exclusion Criteria:
Buenos Aires-San Isidro, 1643, Argentina
Ciudad Autonoma Buenos Aires, C1417, Argentina
Ciudad AutOnoma de Buenos Aire, 1118, Argentina
Ciudad Autonoma de Buenos Aire, C1046AAQ, Argentina
Gauteng, 1619, South Africa